imatinib mesylate has been researched along with Neoplasms, Skull Base in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bay, JO; Bertucci, F; Blay, JY; Bompas, E; Bonneville-Levard, A; Chauffert, B; Chevreau, C; Cupissol, D; Duffaud, F; Fabbro, M; Feuvret, L; Le Cesne, A; Lebellec, L; Mir, O; Noel, G; Penel, N; Saada-Bouzid, E; Vauleon, E; Vinceneux, A | 1 |
| Bruckner, T; Debus, J; Hees, K; Herfarth, K; Jäkel, O; Land, B; Sprave, T; Sterzing, F; Uhl, M; Verma, V | 1 |
| Akgül Babacan, N; Akin Telli, T; Alan, O; Basoglu Tuylu, T; Dane, F; Ercelep, O; Hasanov, R; Kaya, S; Mutis, A; Tanrikulu Simsek, E; Yumuk, PF | 1 |
| Brich, S; Casale, A; Casali, PG; Cavalleri, A; Collini, P; Dinoi, G; Frezza, AM; Gronchi, A; Lo Vullo, S; Mariani, L; Messina, A; Morelli, D; Morosi, C; Palassini, E; Pilotti, S; Stacchiotti, S; Tamborini, E; Venturelli, E | 1 |
| Casali, PG; Crippa, F; Gronchi, A; Marrari, A; Messina, A; Morosi, C; Palassini, E; Pilotti, S; Stacchiotti, S; Tamborini, E; Virdis, E | 1 |
| Bae, SH; Baeg, MK; Jin, JY; Kim, J; Lee, KH; Park, IS | 1 |
| Casali, PG; Gronchi, A; Olmi, P; Sangalli, C; Stacchiotti, S | 1 |
| Boari, N; Doglioni, C; Longoni, M; Mortini, P; Orzan, F; Riva, P; Terreni, MR | 1 |
2 review(s) available for imatinib mesylate and Neoplasms, Skull Base
| Article | Year |
|---|---|
Chordoma: a case series and review of the literature.
Topics: Adult; Aged; Bone Neoplasms; Chordoma; Cranial Fossa, Posterior; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Sacrum; Skull Base Neoplasms; Spinal Neoplasms; Sunitinib | 2018 |
Chordoma.
Topics: Antineoplastic Agents; Benzamides; Chordoma; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sacrococcygeal Region; Skull Base Neoplasms; Spinal Neoplasms | 2007 |
2 trial(s) available for imatinib mesylate and Neoplasms, Skull Base
| Article | Year |
|---|---|
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chordoma; Disease Progression; Everolimus; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Male; Middle Aged; Sarcoma; Skull Base Neoplasms; Spinal Neoplasms; Survival Analysis | 2018 |
Response to imatinib plus sirolimus in advanced chordoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blotting, Western; Chordoma; Female; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Oncogene Protein v-akt; Piperazines; Pyrimidines; Sacrum; Sirolimus; Skull Base Neoplasms; Spinal Neoplasms; Treatment Outcome; Young Adult | 2009 |
4 other study(ies) available for imatinib mesylate and Neoplasms, Skull Base
| Article | Year |
|---|---|
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Chordoma; Erlotinib Hydrochloride; Female; France; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrroles; Retrospective Studies; Sirolimus; Skull Base Neoplasms; Sorafenib; Sunitinib; Treatment Outcome; Young Adult | 2017 |
Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Topics: Antineoplastic Agents; Chordoma; Cost-Benefit Analysis; Disease-Free Survival; Health Care Costs; Heavy Ion Radiotherapy; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Quality-Adjusted Life Years; Skull Base; Skull Base Neoplasms | 2018 |
Diplopia as a presenting symptom in a gastric gastrointestinal stromal tumor.
Topics: Aged; Benzamides; Combined Modality Therapy; Cranial Fossa, Posterior; Diplopia; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Skull Base Neoplasms | 2011 |
Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chordoma; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Skull Base Neoplasms; Stromal Cells | 2007 |